CME Group Inc. (NASDAQ:CME) Sees Significant Decline in Short Interest

CME Group Inc. (NASDAQ:CMEGet Free Report) was the recipient of a large drop in short interest in December. As of December 31st, there was short interest totalling 4,320,000 shares, a drop of 8.7% from the December 15th total of 4,730,000 shares. Based on an average daily volume of 1,950,000 shares, the days-to-cover ratio is presently 2.2 days.

Wall Street Analyst Weigh In

CME has been the subject of several recent analyst reports. Oppenheimer lifted their price target on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday, October 24th. Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target for the company. in a research report on Tuesday, October 8th. Piper Sandler lifted their price target on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a report on Tuesday, January 7th. TD Cowen assumed coverage on CME Group in a report on Thursday, September 26th. They set a “hold” rating and a $221.00 price objective for the company. Finally, The Goldman Sachs Group lifted their target price on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a report on Thursday, October 3rd. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus target price of $229.27.

Check Out Our Latest Research Report on CME Group

Insider Buying and Selling

In related news, insider Sunil Cutinho sold 4,500 shares of the firm’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the sale, the insider now owns 27,053 shares in the company, valued at approximately $6,131,291.92. This trade represents a 14.26 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of the business’s stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the completion of the transaction, the insider now owns 7,275 shares of the company’s stock, valued at $1,652,298. This trade represents a 15.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 7,274 shares of company stock worth $1,648,071. 0.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Harbor Capital Advisors Inc. boosted its stake in CME Group by 0.6% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock valued at $1,723,000 after acquiring an additional 45 shares during the last quarter. CVA Family Office LLC raised its stake in shares of CME Group by 11.8% in the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after purchasing an additional 46 shares in the last quarter. Zions Bancorporation N.A. lifted its position in shares of CME Group by 3.7% during the third quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock worth $338,000 after purchasing an additional 54 shares during the last quarter. Independent Wealth Network Inc. grew its stake in CME Group by 2.1% in the fourth quarter. Independent Wealth Network Inc. now owns 2,683 shares of the financial services provider’s stock worth $623,000 after purchasing an additional 54 shares in the last quarter. Finally, Quent Capital LLC increased its holdings in CME Group by 10.2% in the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after buying an additional 55 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 0.2 %

CME Group stock traded up $0.40 during midday trading on Friday, hitting $232.71. 1,908,705 shares of the company were exchanged, compared to its average volume of 1,567,319. The company has a market cap of $83.86 billion, a PE ratio of 24.47, a price-to-earnings-growth ratio of 4.93 and a beta of 0.56. CME Group has a fifty-two week low of $190.70 and a fifty-two week high of $249.02. The company’s fifty day moving average price is $233.29 and its 200-day moving average price is $219.93. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CMEGet Free Report) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period in the previous year, the company posted $2.25 earnings per share. On average, research analysts predict that CME Group will post 10.2 EPS for the current fiscal year.

CME Group Increases Dividend

The firm also recently announced a dividend, which was paid on Thursday, January 16th. Stockholders of record on Friday, December 27th were paid a dividend of $5.80 per share. The ex-dividend date of this dividend was Friday, December 27th. This is an increase from CME Group’s previous dividend of $2.50. CME Group’s dividend payout ratio (DPR) is currently 48.37%.

CME Group declared that its board has approved a stock buyback program on Thursday, December 5th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the financial services provider to reacquire up to 3.4% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s board believes its stock is undervalued.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.